ENTRY       D11711            Mixture   Drug
NAME        Dapagliflozin, metformin and saxagliptin;
            Qternmet xr (TN)
COMPONENT   Dapagliflozin propanediol [DR:D09763], Metformin hydrochloride [DR:D00944], Saxagliptin hydrate [DR:D09753]
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG03228  Combination of metformin, DPP-4 inhibitor and SGLT2 inhibitor
REMARK      ATC code: A10BD25
EFFICACY    Antidiabetic
  DISEASE   Type 2 diabetes mellitus [DS:H00409]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BD Combinations of oral blood glucose lowering drugs
                 A10BD25 Metformin, saxagliptin and dapagliflozin
                  D11711  Dapagliflozin, metformin and saxagliptin
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Combinations
               Dapagliflozin/ Saxagliptin/ Metformin Hydrochlorid
                D11711  Dapagliflozin, metformin and saxagliptin
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG03228  Combination of metformin, DPP-4 inhibitor and SGLT2 inhibitor
                D11711  Dapagliflozin, metformin and saxagliptin
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11711
DBLINKS     PubChem: 405226577
///
